Log in

NASDAQ:EIGREiger Biopharmaceuticals SEC Filings & 10K Form

$9.64
+0.04 (+0.42 %)
(As of 07/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.45
Now: $9.64
$9.93
50-Day Range
$9.60
MA: $11.41
$13.37
52-Week Range
$4.55
Now: $9.64
$15.82
Volume212,200 shs
Average Volume352,952 shs
Market Capitalization$241.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

SEC Filings

Eiger Biopharmaceuticals (NASDAQ:EIGR) SEC Filings

DateFilerForm TypeView
06/17/2020
4:08 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
7:11 AM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2020
4:17 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
4:16 PM
Eiger Biopharmaceuticals (Issuer)
Glenn Jeffrey S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:40 PM
Eiger Biopharmaceuticals (Issuer)
Shaffer James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:38 PM
Eiger Biopharmaceuticals (Issuer)
Sachdev Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:35 PM
Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:30 PM
Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:29 PM
Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:25 PM
Eiger Biopharmaceuticals (Issuer)
Glenn Jeffrey S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:23 PM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:22 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:20 PM
Apelian David (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
7:31 AM
Eiger Biopharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2020
7:12 AM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
1:29 PM
EcoR1 Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G/A
01/31/2020
6:33 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2020
3:44 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
7:17 AM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
7:10 AM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
7:13 AM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/01/2020
11:15 PM
Eiger Biopharmaceuticals (Filer)
Form EFFECT
12/20/2019
3:51 PM
Eiger Biopharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/16/2019
4:18 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:27 PM
Eiger Biopharmaceuticals (Subject)
Vivo Ventures VI, LLC (Filed by)
Form SC 13D/A
11/07/2019
3:21 PM
Eiger Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
3:12 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
5:37 PM
Eiger Biopharmaceuticals (Issuer)
Shaffer James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
4:47 PM
Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
4:46 PM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
4:30 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K/A
08/08/2019
3:31 PM
Eiger Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:16 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:26 PM
Broadfin Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G
06/12/2019
3:33 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
4:38 PM
Eiger Biopharmaceuticals (Issuer)
Sachdev Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
4:35 PM
Eiger Biopharmaceuticals (Issuer)
Sachdev Amit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/17/2019
3:15 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:17 PM
Eiger Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2019
3:54 PM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
3:34 PM
Eiger Biopharmaceuticals (Filer)
Form DEFA14A
04/26/2019
3:31 PM
Eiger Biopharmaceuticals (Filer)
Form DEF 14A
04/23/2019
5:53 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2019
8:34 PM
Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2019
8:34 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2019
8:31 PM
Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2019
3:35 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
3:32 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
04/17/2019
3:07 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
04/15/2019
3:16 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
9:22 AM
Apelian David (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
9:12 AM
Eiger Biopharmaceuticals (Issuer)
Shaffer James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
9:07 AM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
9:02 AM
Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
9:00 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
8:53 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
8:51 PM
Eiger Biopharmaceuticals (Issuer)
Glenn Jeffrey S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
8:50 PM
Eiger Biopharmaceuticals (Issuer)
Loh Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
8:46 PM
Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
8:45 PM
Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/14/2019
4:14 PM
Eiger Biopharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/08/2019
4:19 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:25 PM
Eiger Biopharmaceuticals (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
Form SC 13G/A
02/14/2019
2:30 PM
Eiger Biopharmaceuticals (Subject)
Vivo Ventures VI, LLC (Filed by)
Form SC 13D/A
02/14/2019
1:27 PM
EcoR1 Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
8:08 AM
Eiger Biopharmaceuticals (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
02/13/2019
4:05 PM
Eiger Biopharmaceuticals (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
02/07/2019
7:40 AM
Eiger Biopharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
02/06/2019
6:23 PM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
3:08 PM
Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
Form SC 13D/A
01/31/2019
11:16 AM
Eiger Biopharmaceuticals (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G/A
01/29/2019
2:23 PM
Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
Form SC 13D/A
01/09/2019
3:15 PM
Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
3:12 PM
Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2019
3:05 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
4:51 PM
Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
1:12 PM
Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2018
7:29 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
3:05 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
4:26 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2018
1:26 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2018
7:51 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
3:01 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2018
2:11 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G
10/25/2018
4:20 PM
Eiger Biopharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/25/2018
4:19 PM
Eiger Biopharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
10/24/2018
5:07 AM
Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
Form SC 13D/A
10/23/2018
4:21 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2018
4:12 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
10/22/2018
3:50 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
10/22/2018
3:33 PM
Desai Keval (Reporting)
Eiger Biopharmaceuticals (Issuer)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2018
3:03 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2018
11:48 AM
Eiger Biopharmaceuticals (Filer)
Form CT ORDER
08/16/2018
3:18 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2018
3:48 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
6:31 AM
Eiger Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/11/2018
4:14 PM
Eiger Biopharmaceuticals (Filer)
Form DEFA14A
06/04/2018
3:03 PM
EcoR1 Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G
05/25/2018
3:43 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2018
3:41 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.